Optidos
510(k) K010705
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK010705 | Date11 Mar 2003 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KXK
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.5730
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Optidos is a Source, Brachytherapy, Radionuclide device, classified as a Class II medical device under FDA regulation 892.5730. It is designed for use in radiology procedures, specifically as a brachytherapy source for internal radiation therapy, delivering precise radioactive emissions to targeted tissue.
Supplied by Ptw-New York Corp., the Optidos is intended for single-use applications in controlled clinical settings. It is regulated under the FDA’s 510(k) clearance process (K010705) and falls under the Radiology advisory committee’s purview. The device is not described as MRI-safe or reusable, and its sterility or storage conditions are not specified in the available data.
Other devices from Ptw-New York Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the Optidos used for in medical procedures?
The Optidos is designed specifically for brachytherapy, a form of internal radiation therapy. It delivers targeted radioactive emissions directly to tissue, allowing precise treatment of localized areas during radiology procedures. This is particularly useful in oncology for treating cancers where external radiation may not be as effective or safe.
Is the Optidos device intended for single-use or reusable applications?
The Optidos is supplied for single-use applications only. This design ensures patient safety and sterility, as single-use devices are not intended to be reused or reprocessed. Reuse could compromise the integrity of the radioactive source and introduce risks to both patients and clinicians.
What regulatory pathway does the Optidos follow, and who oversees its clearance?
The Optidos is classified as a Class II medical device under FDA regulation 892.5730 and follows the 510(k) clearance process. It was reviewed by the FDA’s Radiology Advisory Committee (RA) and received clearance under the traditional pathway with the decision code SESE (Substantially Equivalent). The clearance number assigned is K010705.
Are there specific storage conditions or sterility guarantees mentioned for the Optidos?
The available data does not specify storage conditions or sterility guarantees for the Optidos. Clinicians should follow standard radiation safety protocols for handling radioactive sources and consult manufacturer guidelines for proper storage and handling to ensure safety and efficacy.
What types of radiology procedures can the Optidos be used in?
The Optidos is intended for use in brachytherapy procedures within radiology, where precise internal radiation delivery is required. This includes treatments for cancers such as prostate, cervical, or breast cancer, where localized radiation is administered directly to the tumor site. Its use is restricted to controlled clinical settings where trained professionals can manage radioactive materials safely.